Prof. Kostas Papagiannopoulos: six key points of technique for pulmonary segmentectomy

Zhuoqi Jia, Molly J. Wang

Abstract

Lung cancer is the leading cause of cancer death among men and women in the world. Fewer than 15% achieve a 5-year survival. The vast majority (85%) present with advanced disease, although stage I patients may have a 5-year survival approaching 70%. R0 resection remains the standard treatment of choice for patients with clinical stages IA, IB, IIA, and non-T3N0 stage IIB NSCLC. Some controversies exist regarding the choice of procedure and technique that will meet surgical oncologic principles: conservative resection as a definitive alternative to lobectomy or pneumonectomy, or segmental resection, SBRT and so on.